MetaCap

60 Degrees Pharmaceuticals Insider Trades

NASDAQ: SXTPHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.4682-0.0318 (-6.36%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
4 · $30.09K
Sales
0 · $0
Shares bought / sold
29.98K / 0
Net activity
Net buying $30,095

60 Degrees Pharmaceuticals insider activity

Over the last 12 months, 60 Degrees Pharmaceuticals insiders reported 4 transactions on SEC Form 4: 4 open-market purchases and 0 sales. Insiders bought $30,095 and sold $0 worth of stock, for net insider buying of $30,095. The most recent filing shows DOW GEOFFREY S (President and CEO) buying 7,350 shares at $1.38 on Jun 12, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put SXTP's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

SXTP insider transactions

60 Degrees Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Jun 12, 2026DOW GEOFFREY SPresident and CEOBuy7,350$10.13KForm 4
Dec 15, 2025DOW GEOFFREY SPresident and CEOBuy9,670$7.76KForm 4
Dec 11, 2025DOW GEOFFREY SPresident and CEOBuy3,613$3.32KForm 4
Dec 10, 2025DOW GEOFFREY SPresident and CEOBuy9,350$8.89KForm 4
Sep 12, 2025DOW GEOFFREY SPresident and CEOAward7,201$10.00KForm 4
Jun 9, 2025DOW GEOFFREY SPresident and CEOAward4,376$13.06KForm 4
Jun 3, 2025XU CHERYLDirectorBuy2,000$5.80KForm 4
Jun 3, 2025XU CHERYLDirectorBuy3,000$8.61KForm 4
Jan 17, 2025DOW GEOFFREY SPresident and CEOAward14,394—Form 4
Jan 17, 2025MILLER TYRONECFOAward11,626—Form 4
Jan 17, 2025Landon KristenChief Operating OfficerAward4,540—Form 4
Dec 16, 2024XU CHERYLDirectorBuy2,000$2.90KForm 4
Dec 13, 2024XU CHERYLDirectorBuy1,500$2.28KForm 4
Dec 13, 2024XU CHERYLDirectorBuy1,500$2.33KForm 4
Dec 13, 2024XU CHERYLDirectorBuy1,500$2.37KForm 4
Dec 13, 2024XU CHERYLDirectorBuy1,500$2.40KForm 4
Dec 12, 2024XU CHERYLDirectorBuy2,500$4.50KForm 4
Dec 12, 2024XU CHERYLDirectorBuy2,500$4.63KForm 4
Dec 9, 2024DOW GEOFFREY SPresident and CEOBuy35,823$45.56KForm 4
Dec 6, 2024DOW GEOFFREY SPresident and CEOBuy20,579$24.67KForm 4
Dec 5, 2024DOW GEOFFREY SPresident and CEOBuy17,549$19.52KForm 4
Nov 21, 2024DOW GEOFFREY SPresident and CEOBuy3,500$3.20KForm 4
Nov 20, 2024DOW GEOFFREY SPresident and CEOBuy1,000$924.30Form 4
Nov 19, 2024DOW GEOFFREY SPresident and CEOBuy2,500$2.25KForm 4
Aug 27, 2024XU CHERYLDirectorBuy5,000$8.50KForm 4
May 16, 2024Allen Charles WDirectorOption exercise4,000$892Form 4
May 16, 2024DOW GEOFFREY SPresident and CEOOption exercise17,000$3.79KForm 4
May 16, 2024FIELD PAULDirectorOption exercise4,000$892Form 4
May 16, 2024TOOVEY STEPHENDirectorAward4,000$892Form 4
May 16, 2024MILLER TYRONECFOAward15,000$3.35KForm 4
May 16, 2024XU CHERYLDirectorOption exercise2,000$446Form 4
Apr 12, 2024DOW GEOFFREY SPresident and CEOOption exercise68,000$18.14KForm 4
Apr 12, 2024MILLER TYRONECFOAward60,000$16.01KForm 4
Feb 1, 2024XU CHERYLDirectorOption exercise2,000—Form 4
Jan 31, 2024DOW GEOFFREY SPresident and CEOBuy25,974$9.74KForm 4
Jan 31, 2024XU CHERYLDirectorBuy200,000$75.00KForm 4
Jul 28, 2023Knight Therapeutics Inc & KNIGHT THERAPEUTICS INTERNATIONAL SAFormer 10% OwnerConversion2,162—Form 4
Jul 28, 2023Knight Therapeutics Inc & KNIGHT THERAPEUTICS INTERNATIONAL SAFormer 10% OwnerConversion45,560$216.18KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related